What is Clarium?
Founded in 2020 by Steve Liou, Clarium operates at the intersection of enterprise software and healthcare logistics. The company's flagship product, Astra OS, serves as a centralized intelligence layer designed to unify disparate data streams across hospital supply chains. By providing real-time visibility and intelligent workflow automation, Clarium enables providers to transition from reactive procurement models to proactive, data-backed decision-making. The platform has already gained significant traction among prestigious health systems, including Yale New Haven Health, Stanford, and Geisinger, validating its utility in high-stakes medical environments. Clarium's market position is defined by its ability to solve the 'last mile' of hospital operations, where supply chain disruptions can directly impact patient outcomes and institutional financial health.
How much funding has Clarium raised?
Clarium has raised a total of $37.5M across 2 funding rounds:
Other Financing Round
$10.5M
Series A
$27M
Other Financing Round (2024): $10.5M with participation from General Catalyst, Yale New Haven Health, and Kaiser Permanente Ventures
Series A (2025): $27M led by 1984 Ventures, AlleyCorp companies, Kaiser Permanente, General Catalyst, and Texas Medical Center
Key Investors in Clarium
General Catalyst
A prominent venture capital firm that partners with founders to build enduring enterprises by providing deep sector expertise and operational support across the healthcare and enterprise software verticals.
Kaiser Permanente
A leading not-for-profit healthcare organization that integrates medical services with insurance, known for its commitment to technological innovation and community health initiatives.
1984 Ventures
A venture capital firm specializing in early-stage startups, focused on identifying and nurturing high-potential companies at the seed and Series A levels.
What's next for Clarium?
With this latest capital infusion, Clarium is well-positioned to accelerate its product roadmap and expand its footprint within the North American healthcare market. The strategic backing from industry-heavyweight investors suggests a focus on scaling the Astra OS platform to support more complex, multi-facility health networks. Future growth will likely center on deepening the platform's predictive analytics capabilities and expanding integrations with existing electronic health record (EHR) systems. As Clarium continues to mature, the company is expected to play a pivotal role in the digital transformation of hospital operations, potentially setting new standards for supply chain resilience and operational excellence in the healthcare sector.
See full Clarium company page
